Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Japanstore LLC - An expert in the field of Asian care
Medicare Utilization of GLP-1s Rises with Broader Indications Beyond Obesity Since Medicare does not cover anti obesity drugs when prescribed solely for weight management, utilization of weight loss indicated GLP-1s historically lagged behind their use in commercial markets
Importantly, GLP-1 receptor agonists are not indicated for type 1 diabetes or diabetic ketoacidosis
In a recent study of 154 non-diabetic subjects, weight loss averaged 12 lbs over the 6-month study
US$ 25.23
US$ 20.21
US$ 20.73
US$ 28.67
US$ 24.79
US$ 20.31
US$ 19.98
US$ 26.37
US$ 27.56
